HCA Healthcare, Inc. (HCA) Earnings History
Annual and quarterly earnings data from 1990 to 2025
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 41.5% | 15.8% | 9.0% |
| 2024 | 40.6% | 14.9% | 8.2% |
| 2023 | 39.4% | 14.8% | 8.1% |
| 2022 | 38.5% | 15.0% | 9.4% |
| 2021 | 38.3% | 16.5% | 11.8% |
Download Data
Export HCA earnings history in CSV or JSON format
Free sign-in required to download data
HCA Healthcare, Inc. (HCA) Earnings Overview
As of February 28, 2026, HCA Healthcare, Inc. (HCA) reported trailing twelve-month net income of $6.78B, reflecting +0.3% year-over-year growth. The company earned $29.40 per diluted share over the past four quarters, with a net profit margin of 0.1%.
Looking at the long-term picture, HCA's 5-year EPS compound annual growth rate (CAGR) stands at +21.0%, indicating exceptional earnings growth. The company achieved its highest annual net income of $6.96B in fiscal 2021.
HCA Healthcare, Inc. maintains positive profitability with a gross margin of 0.4%, operating margin of 0.2%, and net margin of 0.1%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including THC ($1.41B net income, 0.1% margin), MPW (-$199M net income, -0.2% margin), ACHC (-$1.10B net income, -0.3% margin), HCA has outperformed on profitability metrics. Compare HCA vs THC →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
36 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.78B | +17.8% | $11.96B | $28.38 | 9.0% | 15.8% |
| 2024 | $5.76B | +9.9% | $10.55B | $22.00 | 8.2% | 14.9% |
| 2023 | $5.24B | -7.1% | $9.63B | $18.96 | 8.1% | 14.8% |
| 2022 | $5.64B | -18.9% | $9.05B | $19.15 | 9.4% | 15.0% |
| 2021 | $6.96B | +85.3% | $9.68B | $21.16 | 11.8% | 16.5% |
| 2020 | $3.75B | +7.1% | $7.26B | $10.93 | 7.3% | 14.1% |
| 2019 | $3.50B | -7.4% | $7.22B | $10.07 | 6.8% | 14.1% |
| 2018 | $3.79B | +70.9% | $6.64B | $10.66 | 8.1% | 14.2% |
| 2017 | $2.22B | -23.3% | $6.06B | $5.95 | 5.1% | 13.9% |
| 2016 | $2.89B | +35.7% | $6.20B | $7.30 | 7.0% | 14.9% |
See HCA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HCA Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare HCA vs AGIO
See how HCA stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is HCA growing earnings?
HCA EPS of $29.40 reflects slowing growth at +0.3%, below the 5-year CAGR of +21.0%. TTM net income is $6.8B. Expansion rate has moderated.
What are HCA's profit margins?
HCA Healthcare, Inc. net margin is +0.1%, with operating margin at +0.2%. Below-average margins reflect competitive or cost pressures.
How consistent are HCA's earnings?
HCA earnings data spans 1990-2025. The current earnings trend is +0.3% YoY. Historical data enables comparison across business cycles.